Status:
UNKNOWN
Prevalence and Burden of Hepatitis D Virus Infection in China Through Preoperative Examination Test (Predict Study)
Lead Sponsor:
The First Affiliated Hospital with Nanjing Medical University
Collaborating Sponsors:
Gilead Sciences
Conditions:
Hepatitis D
Hepatitis B
Eligibility:
All Genders
18+ years
Brief Summary
In China, there is no recommendation for Hepatitis D virus (HDV) screening, but the fact is estimated that one-third of the world's population of individuals with chronic Hepatitis B virus (HBV) infec...
Eligibility Criteria
Inclusion
- Positive HBV surface antigen (HBsAg)
- Age 18 yeas and above
Exclusion
- 1\. Severe cardiac, renal, respiratory, hematological, or psychiatric illness.
Key Trial Info
Start Date :
November 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2023
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT05394623
Start Date
November 1 2022
End Date
July 1 2023
Last Update
November 2 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.